Aurora Biopharma CEO and leadership

Robert Brooks brings over twenty years of extensive corporate and investment banking experience. From 1986 to 2007, he was employed with NYSE and FINRA member firms as an investment banker, and raised hundreds of millions of dollars of capital for life science and other small capitalized companies. Since 1999, Mr. Brooks practiced corporate securities, real estate and venture capital law. Mr. Brooks has been the president of US Global Capital, LLC, a financial advisory. He is also the CEO of biotechnology companies Metabogenix Technologies, Inc., and Medvax Technologies, Inc. He holds a Juris Doctorate from the University of Miami Law School, Miami, Florida, and B.S. in Zoology/Pre-Medicine from the University of Massachusetts. He is admitted to the Florida Bar, U.S. District Court (S.D. of FL), and U.S. Tax Court. and Court of International Trade. He holds a securities license with Freedom Investors Corp.

Marc is the Kathleen and Stanley Glaser Professor of Medicine and Deputy Director of the University of Miami Sylvester Comprehensive Cancer Center. Previously, from February 2001 to May 2007 he served as the John G. Searle Professor and Chairman of the Department of Internal Medicine at the University of Michigan School of Medicine. Previously, Dr. Lippman was the Director of the Lombardi Cancer Research Center from July 1988 to February 2001, Professor and Chairman of the Department of Oncology from July 1999 to February 2001 and Professor of Medicine at Georgetown University Medical School in Washington, D.C. from July 1988 to February 2001. He also served as Chief of the Division of Hematology-Oncology at Georgetown University Medical School from July 1995 to February 2001. He was Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute from July 1976 to July 1988. Dr. Lippman has authored over 500 peer- reviewed publications.

Robert Brooks brings over twenty years of extensive corporate and investment banking experience. From 1986 to 2007, he was employed with NYSE and FINRA member firms as an investment banker, and raised hundreds of millions of dollars of capital for life science and other small capitalized companies. Since 1999, Mr. Brooks practiced corporate securities, real estate and venture capital law. Mr. Brooks has been the president of US Global Capital, LLC, a financial advisory. He is also the CEO of biotechnology companies Metabogenix Technologies, Inc., and Medvax Technologies, Inc. He holds a Juris Doctorate from the University of Miami Law School, Miami, Florida, and B.S. in Zoology/Pre-Medicine from the University of Massachusetts. He is admitted to the Florida Bar, U.S. District Court (S.D. of FL), and U.S. Tax Court. and Court of International Trade. He holds a securities license with Freedom Investors Corp.

Marc is the Kathleen and Stanley Glaser Professor of Medicine and Deputy Director of the University of Miami Sylvester Comprehensive Cancer Center. Previously, from February 2001 to May 2007 he served as the John G. Searle Professor and Chairman of the Department of Internal Medicine at the University of Michigan School of Medicine. Previously, Dr. Lippman was the Director of the Lombardi Cancer Research Center from July 1988 to February 2001, Professor and Chairman of the Department of Oncology from July 1999 to February 2001 and Professor of Medicine at Georgetown University Medical School in Washington, D.C. from July 1988 to February 2001. He also served as Chief of the Division of Hematology-Oncology at Georgetown University Medical School from July 1995 to February 2001. He was Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute from July 1976 to July 1988. Dr. Lippman has authored over 500 peer- reviewed publications.

Robert Brooks brings over twenty years of extensive corporate and investment banking experience. From 1986 to 2007, he was employed with NYSE and FINRA member firms as an investment banker, and raised hundreds of millions of dollars of capital for life science and other small capitalized companies. Since 1999, Mr. Brooks practiced corporate securities, real estate and venture capital law. Mr. Brooks has been the president of US Global Capital, LLC, a financial advisory. He is also the CEO of biotechnology companies Metabogenix Technologies, Inc., and Medvax Technologies, Inc. He holds a Juris Doctorate from the University of Miami Law School, Miami, Florida, and B.S. in Zoology/Pre-Medicine from the University of Massachusetts. He is admitted to the Florida Bar, U.S. District Court (S.D. of FL), and U.S. Tax Court. and Court of International Trade. He holds a securities license with Freedom Investors Corp.

Marc is the Kathleen and Stanley Glaser Professor of Medicine and Deputy Director of the University of Miami Sylvester Comprehensive Cancer Center. Previously, from February 2001 to May 2007 he served as the John G. Searle Professor and Chairman of the Department of Internal Medicine at the University of Michigan School of Medicine. Previously, Dr. Lippman was the Director of the Lombardi Cancer Research Center from July 1988 to February 2001, Professor and Chairman of the Department of Oncology from July 1999 to February 2001 and Professor of Medicine at Georgetown University Medical School in Washington, D.C. from July 1988 to February 2001. He also served as Chief of the Division of Hematology-Oncology at Georgetown University Medical School from July 1995 to February 2001. He was Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute from July 1976 to July 1988. Dr. Lippman has authored over 500 peer- reviewed publications.